• Tidak ada hasil yang ditemukan

Supplementary Table of BRCA1 and BRCA2 Primers for Sanger Verification

N/A
N/A
Protected

Academic year: 2023

Membagikan "Supplementary Table of BRCA1 and BRCA2 Primers for Sanger Verification"

Copied!
2
0
0

Teks penuh

(1)

Supplementary Table 2: M13F tagged primers used to Sanger verify BRCA1 and BRCA2 variants.

Primer Name Chromosome Location Primer sequence (all F primers are M13 tagged) BRCA1 p.T1726S F chr17:41203095 GTAAAACGACGGCCAGTGCTGTTTTGTTTGGAGAGTGG BRCA1 p.T1726S R chr17:41203095 CCTGGGAAGTAGCAGCAGAA

BRCA1 p.S1465I F chr17:41226488 GTAAAACGACGGCCAGTCTCTTCCAGCTGTTGCTCCT BRCA1 p.S1465I R chr17:41226488 GCTGCCCAGCAAGTATGATT

BRCA1 p.R1300G F chr17:41243509 GTAAAACGACGGCCAGTTGCTCCCCAAAAGCATAAAC BRCA1 p.R1300G R chr17:41243509 CACCCAGGATCCTTTCTTGA

BRCA1 p.N1189K F chr17:41243840 GTAAAACGACGGCCAGTGAAAGGATCCTGGGTGTTTG BRCA1 p.N1189K R chr17:41243840 CAAAAGCGTCCAGAAAGGAG

BRCA1 p.E1172D F chr17:41243891 GTAAAACGACGGCCAGTTGCCTTTGCCAATATTACCTG BRCA1 p.E1172D R chr17:41243891 CAAAAGCGTCCAGAAAGGAG

BRCA1 f/s F chr17:41244865 GTAAAACGACGGCCAGTTTTCGTTGCCTCTGAACTGA BRCA1 f/s R chr17:41244865 AACCACAGTCGGGAAACAAG

BRCA1 p.T779K F chr17:41245071 GTAAAACGACGGCCAGTGGATTTGAAAACGGAGCAAA BRCA1 p.T779K R chr17:41245071 GGAAGGCAAAAACAGAACCA

BRCA1 p.Q516X F chr17:41245861 GTAAAACGACGGCCAGTCGCATGAATATGCCTGGTAG BRCA1 p.Q516X R chr17:41245861 CATCAGGCCTTCATCCTGAG

BRCA1 p.D167G F chr17:41247892 GTAAAACGACGGCCAGTTGGGTTGTAAAGGTCCCAAA BRCA1 p.D167G R chr17:41247892 CCCAGCAACCATTTCATTTC

BRCA1 splice F chr17:41247941 GTAAAACGACGGCCAGTTGGGTTGTAAAGGTCCCAAA BRCA1 splice R chr17:41247941 CCCAGCAACCATTTCATTTC

BRCA2 p.Y42C F chr13:32893271 GTAAAACGACGGCCAGTTCGCAAGAGAATGGATTAATGA BRCA2 p.Y42C R chr13:32893271 GATTGGTACAGCGGCAGAGT

BRCA2 p.A75P F chr13:32893369 GTAAAACGACGGCCAGTTTCTTCAGAAGCTCCACCCTA BRCA2 p.A75P R chr13:32893369 GGCCAGAGAGACTGATTTGC

BRCA2 p.F81I F chr13:32893387 GTAAAACGACGGCCAGTTTCTTCAGAAGCTCCACCCTA BRCA2 p.F81I R chr13:32893387 GGCCAGAGAGACTGATTTGC

BRCA2 p.S384F F chr13:32906766 GTAAAACGACGGCCAGTAGCAAACGCTGATGAATGTG BRCA2 p.S384F R chr13:32906766 GGCTAGAAATACGTGGCAAA

BRCA2 p.S489C F chr13:32907081 GTAAAACGACGGCCAGTTTTGCCACGTATTTCTAGCC BRCA2 p.S489C R chr13:32907081 AGGAGTCCTCCTTCTGTGAGC

BRCA2 p.I505T F chr13:32907129 GTAAAACGACGGCCAGTTTTGCCACGTATTTCTAGCC BRCA2 p.I505T R chr13:32907129 AGGAGTCCTCCTTCTGTGAGC

BRCA2 p.T598A F chr13:32907407 GTAAAACGACGGCCAGTGCCTCTGAAAGTGGACTGGA BRCA2 p.T598A R chr13:32907407 AAAGCATTTGCTTCAAACTGG

BRCA2 p.S617P F chr13:32907464 GTAAAACGACGGCCAGTGCCTCTGAAAGTGGACTGGA BRCA2 p.S617P R chr13:32907464 CCATGTTTGAGTGACCTGATTC

BRCA2 p.935H F chr13:32911295 GTAAAACGACGGCCAGTTCAATCCAGACTCTGAAGAACTTTT BRCA2 p.935H R chr13:32911295 AGTCCTGCCCATTTGTTCAT

BRCA2 p.935N F chr13:32911295 GTAAAACGACGGCCAGTTCAATCCAGACTCTGAAGAACTTTT BRCA2 p.935N R chr13:32911295 AGTCCTGCCCATTTGTTCAT

BRCA2 p.R1382del F chr13:32912638 GTAAAACGACGGCCAGTTGGCACTTTTGTTGAAGAAATTA BRCA2 p.R1382del R chr13:32912638 AAATGACTCTTTGGCGACACT

BRCA2 p.D1420Y F chr13:32912750 GTAAAACGACGGCCAGTGGAAGTTGCGAAAGCTCAAG BRCA2 p.D1420Y R chr13:32912750 TTCCAGTACCAACTGGGACAC

BRCA2 p.I1705V F chr13:32913605 GTAAAACGACGGCCAGTAAACAGCAAAAAGTCCTGCAA BRCA2 p.I1705V R chr13:32913605 CCTCATCAGAATGGTAGGAATAGC

(2)

Primer Name Chromosome Location Primer sequence (all F primers are M13 tagged) BRCA2 p.L1908P F chr13:32914215 GTAAAACGACGGCCAGTGCCAGTGGTAAAATCGTTTG BRCA2 p.L1908P R chr13:32914215 TTCCAAACTAACATCACAAGGTG

BRCA2 p.R2034C F chr13:32914592 GTAAAACGACGGCCAGTTGGGATTTTTAGCACAGCAA BRCA2 p.R2034C R chr13:32914592 TGGAAACTTGCTTTCCACTTG

BRCA2 p.S2247G F chr13:32915231 GTAAAACGACGGCCAGTTGGGAAAAGAACAGGCTTCA BRCA2 p.S2247G R chr13:32915231 TGGCAACACGAAAGGTAAAA

BRCA2 p.A2671S F chr13:32937350 GTAAAACGACGGCCAGTTGGAATTCTAGAGTCACACTTCCTAA BRCA2 p.A2671S R chr13:32937350 CTGGGCCTTAACAGCATACC

BRCA2 p.A2717S F chr13:32937488 GTAAAACGACGGCCAGTATGGAAAGGGATGACACAGC BRCA2 p.A2717S R chr13:32937488 ATTCTGGGGCTTCAAGAGGT

BRCA2 p.V2728I F chr13:32937521 GTAAAACGACGGCCAGTATGGAAAGGGATGACACAGC BRCA2 p.V2728I R chr13:32937521 ATTCTGGGGCTTCAAGAGGT

BRCA2 p.E2856A F chr13:32945172 GTAAAACGACGGCCAGTCTCAGCCTCCCAAAGTTCTG BRCA2 p.E2856A R chr13:32945172 TGTCCCTTGTTGCTATTCTTTG

BRCA2 p.K2950N F chr13:32953549 GTAAAACGACGGCCAGTTGGTCACAGGGTTATTTCAGTG BRCA2 p.K2950N R chr13:32953549 GGGCATTAGTAGTGGATTTTGC

BRCA2 p.A2951T F chr13:32953550 GTAAAACGACGGCCAGTTGGTCACAGGGTTATTTCAGTG BRCA2 p.A2951T R chr13:32953550 GGGCATTAGTAGTGGATTTTGC

BRCA2 p.T3013I F chr13:32953971 GTAAAACGACGGCCAGTTTCTTCCATTGCATCTTTCTCA BRCA2 p.T3013I R chr13:32953971 CCGTGGCTGGTAAATCTGAA

BRCA2 p.K3326X F chr13:32972626 GTAAAACGACGGCCAGTCATTTCAGCCACCAAGGAGT BRCA2 p.K3326X R chr13:32972626 AACTGGTGGGAGCAGTCCTA

Referensi

Dokumen terkait

Supplementary table 2: The response of Clinically Pertinent Questions Representing Most of the QOL Domains in the 9 Adult Chronic Intestinal Pseudo-Obstruction CIPO Recipients with

LIST OF FIGURES AND TABLES Table 1 Seed stocks Table 2 Primers used for PCR amplification of targeted gene regions Table 3 PCR conditions for amplification of targeted gene regions

Specifically, we show how SPIN, a tool used for the formal systems verification purposes, can be used to verify as well as quickly identify problematic behaviors if any in core

17 Supplementary Table 6 Comparison of linear model logDOC concentration mg / L vs variable slopes between US and Australian data for climate variables after confining US data to the

Supplementary Table 2: Dynamic functional connectivity between the sgACC and Salience Network and the sgACC and Descending Antinociceptive System in chronic pain patients and healthy

In this paper, we analyze the performance of several islanding detection techniques presented in the literature and propose a modified 9-bus benchmark system to verify the robustness of

Supplementary Table 8: Sensitivity analysis - Including site with implementation inconsistencies multivariable risk factors at first-line failure Characteristic Adjusted

Supplementary Table 1: Clinical and laboratory features of 8 individuals with Turner Syndrome and Duchenne Muscular Dystrophy Author, year Karyotype Age of TS diagnosis years Age of